Gsa Capital Partners LLP En V Veno Medical Corp Transaction History
Gsa Capital Partners LLP
- $1.2 Billion
- Q3 2025
A detailed history of Gsa Capital Partners LLP transactions in En V Veno Medical Corp stock. As of the latest transaction made, Gsa Capital Partners LLP holds 13,420 shares of NVNO stock, worth $5,636. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,420Holding current value
$5,636% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVNO
# of Institutions
42Shares Held
6.36MCall Options Held
116KPut Options Held
12K-
Perceptive Advisors LLC New York, NY1.76MShares$738,7940.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.36MShares$570,8890.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA861KShares$361,7000.0% of portfolio
-
Cm Management, LLC600KShares$252,0000.51% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$168,5043.48% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $3.98M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...